Found 13 matching trials
Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C
PHASE3This study is to evaluate the overall efficacy, and safety profile of the t...
Location
Novartis Investigative Site
Efficacy of Pegylated Interferon Alone in Egyptian Patients With Acute Hepatitis C (ANRS 1213)
PHASE3Acute hepatitis C is a liver disease related to a virus: hepatitis C virus ...
Location
National Hepatology and Tropical Medicine Research Institute
Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection
PHASE2This is a randomized, open label, multicenter Phase 2 study investigating t...
Location
Arizona Liver Health
A Study of Debio 025 (Alisporivir) Combined With Peg-IFNα2a and Ribavirin in Treatment naïve Chronic Hepatitis C Genotype 1 Patients
NAThe purpose of this study is to compare several Debio 025 (alisporivir)/peg...
Location
Cliniques Universitaires Saint-Luc
Chronic Hepatitis C Treatment by Pegylated Interferon and Ribavirin in Naive Egyptian Patients (ANRS 1211)
PHASE3Chronic hepatitis C is a liver disease related to a virus: hepatitis C viru...
Location
Ismail Sallam hospital
Pharmacokinetics, Pharmacodynamics and Safety of DEB025 Plus Ribavirin in Chronic Hepatitis C Genotype 2 and 3 Treatment naïve Patients
NAThis study will explore the relationship of different DEB025 doses in combi...
Location
Novartis Investigative Site
Efficacy and Safety of Alisporivir Triple Therapy in Chronic Hepatitis C Genotype 1 Treatment-naïve Participants
PHASE3This study will assess the safety and efficacy of alisporivir (ALV; DEB025)...
Location
Novartis Investigative Site
A Study of Debio 025 in Combination With PegIFN Alpha-2a and Ribavirin in Chronic HCV Patients Non-responders to Standard Treatment
PHASE2Debio 025 (alisporivir) is an oral cyclophilin inhibitor with a new mechani...
Location
Scripps Clinic Liver Disease Research Center
A Study of PEGASYS (Peginterferon Alfa-2a) Plus Ribavirin in Patients With Chronic Hepatitis C (CHC), Genotype 2 or 3
PHASE4This randomized, parallel arm study will evaluate the efficacy and safety o...
Location
Multiple Locations
Efficacy and Safety of Alisporivir Alone or Combined With RBV or PEG in Chronic Hepatitis C Genotype 2 and 3 Treatment-naïve Participants
PHASE2The study is to investigate whether alisporivir (ALV; DEB025) alone or in c...